Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Astudillo

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Neurology|December 12, 2024
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter studyMaxime Brachet, Sybil Charrière, Claire Douillard, et al.
Molecular Genetics and Metabolism|December 20, 2025
Neurological and psychiatric issues in 187 adults with early-treated PKU: The ECOPHEN studyChloé Giret, Sybil Charrière, François Feillet, et al.
Journal of Inherited Metabolic Disease|March 20, 2025
Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-UpAlberto Nasce, Yann Nguyen, Nadia Belmatoug, et al.
Journal of Clinical Medicine|July 26, 2020
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher DiseaseChristine Serratrice, Jérôme Stirnemann, Amina Berrahal, et al.
International Journal of Molecular Sciences|February 20, 2020
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease RegistryYann Nguyen, Jérôme Stirnemann, Florent Lautredoux, et al.
Journal of Inherited Metabolic Disease|May 10, 2025
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three DecadesYann Nguyen, Maxime Beydon, Karima Yousfi, et al.
Journal of Internal Medicine|February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulationMaxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Autoimmunity Reviews|September 16, 2014
Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter studyAntoine Néel, Benoit Henry, Sebastien Barbarot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Neurology|December 12, 2024
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter studyMaxime Brachet, Sybil Charrière, Claire Douillard, et al.
Molecular Genetics and Metabolism|December 20, 2025
Neurological and psychiatric issues in 187 adults with early-treated PKU: The ECOPHEN studyChloé Giret, Sybil Charrière, François Feillet, et al.
Journal of Inherited Metabolic Disease|March 20, 2025
Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-UpAlberto Nasce, Yann Nguyen, Nadia Belmatoug, et al.
Journal of Clinical Medicine|July 26, 2020
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher DiseaseChristine Serratrice, Jérôme Stirnemann, Amina Berrahal, et al.
International Journal of Molecular Sciences|February 20, 2020
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease RegistryYann Nguyen, Jérôme Stirnemann, Florent Lautredoux, et al.
Journal of Inherited Metabolic Disease|May 10, 2025
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three DecadesYann Nguyen, Maxime Beydon, Karima Yousfi, et al.
Journal of Internal Medicine|February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulationMaxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Autoimmunity Reviews|September 16, 2014
Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter studyAntoine Néel, Benoit Henry, Sebastien Barbarot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.
Pageof 4